Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852852 · ClinicalTrials.gov registry record · NA
Computerized Assessment for Patients With Cancer
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 779
- Enrollment target
NCT00852852 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 779 participants.
The verdict
NCT00852852, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 779 participants
- Enrollment target
Study Summary
This research study will test a new online computer program for patients, the Electronic Self-Report Assessment-Cancer (ESRA-C 2). The program allows patients to report symptoms and quality of life issues and learn information about how to deal with these experiences. The computer program is being tested to see if it can improve communications between patients and their care team and if it can improve patients' experiences during and after treatment.
Interventions
- BEHAVIORAL Electronic Self-Report Assessment - Cancer (ESRA-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 779 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852852
The ClinicalTrials.gov registry entry for NCT00852852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 779 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Self-Report Assessment - Cancer (ESRA-C) is the first listed.
NCT00852852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852852 about?
NCT00852852 is a clinical study titled "Computerized Assessment for Patients With Cancer". This research study will test a new online computer program for patients, the Electronic Self-Report Assessment-Cancer (ESRA-C 2). The program allows patients to report symptoms and quality of life issues and learn information about how to deal with these experiences. The computer program is being t...
What is the current status of trial NCT00852852?
This trial is currently completed. It is a NA study. The enrollment target is 779 participants. The study started on 2008-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00852852?
The interventions under investigation include: Electronic Self-Report Assessment - Cancer (ESRA-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00852852?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.